detecting skull base cerebrospinal fluid leaks. 2) Develop a comprehensive algorithm for the diagnostic workup of anterior skull base cerebrospinal fluid leaks.
Objective: 1) To describe the utility of current sialendoscopes in the paranasal sinuses in a cadaveric model. 2) To suggest the novel uses for sialendoscopes and potential improvements in design.
Method: A cadaveric study was performed in a tertiary care hospital setting in October 2011. Currently available sialendoscopes were used for visualization and interventions in the paranasal sinuses. Four cadaver heads were studied pre-and postdissection. Outcomes included identification of ostia, cannulation of sinuses, success of mucosal biopsy, and clarity of images.
Results: There were no significant differences in types of scopes. Both Marchal and Erlangen scopes were demonstrated to be effective in both visualizing and cannulating the sphenoid sinuses in pre-and postdissected settings (8/8). Neither type allowed for adequate visualization of the maxillary ostia without dissection, but did allow for evaluation and cannulation after antrostomy. Larger diameter scopes were associated with the least distortion of image during assessment of the maxillary ostia. Mucosal biopsy within the sphenoid sinus was possible before dissection, but not in the maxillary sinus.
Conclusion:
Sialendoscopes can be used for visualization and interventions in the sinonasal cavity but are limited mainly to the sphenoid sinus. They may be considered as a minimallyinvasive method for drug delivery and/or biopsy in the postoperative setting for all sinuses. The design can be improved somewhat.
Sleep Medicine allergic Rhinitis and Changing Nasal Congestion after Continuous Positive airwary Pressure
Jonathan R. Skirko, MD, MHPA; (presenter); Kathryn T. James; Corinna G. Levine; Dennis Shusterman; Edward M. Weaver, MD, MPH Objective: Among continuous positive airway pressure (CPAP) users, self-reported allergic rhinitis has been associated with relative worsening of subjective nasal congestion. This study's aims were to test the associations between objective allergic rhinitis status and 1) change in objective nasal congestion after CPAP initiation, or 2) objective CPAP use.
Method: Objective allergic rhinitis status was established by skin-prick test of 17 region-specific aeroallergens in CPAP patients with baseline turbinate hypertrophy. Objective nasal congestion was measured by acoustic rhinometry (combined bilateral minimal cross-sectional area, MCA) at baseline and 3-months later in subjects using CPAP. Objective CPAP use was measured at 12 months.
Results: This cohort study included n = 81 subjects from a larger parent trial on turbinate hypertrophy in CPAP patients. In this cohort, MCA did not change significantly in subjects with allergic rhinitis (n = 51, paired t-test P = .18) or in controls (n = 30, paired t-test P = .67) after initiation of CPAP, and there was no significant difference in change between groups (t-test P = .28). CPAP use in allergic rhinitis subjects (1.9 ± 2.7 h/night) was not significantly different from controls (2.4 ± 3.0 h/night; Mann-Whitney U test, P = .28), but statistical power was limited for the observed difference (power 12%).
Conclusion: Allergic rhinitis did not predict worsening of objective nasal congestion with CPAP initiation or decreased CPAP use, but confounding, eligibility criteria, limits of objective nasal measurements, and insufficient statistical power may have blunted a true effect. Further studies are needed.
Sleep Medicine application of a Novel Bioabsorbable tonsil Patch Patrick C. Melder, MD (presenter)
Objective: 1) To learn if application of a novel bioabsorbable material is feasible for use as a posttonsillectomy patch. 2) To determine, based on the limited number of cases, if there is subjective evidence of decreased pain and quicker return to normal diet. 3) To determine if further research is warranted.
Method:
The current study was a nonrandomized clinical study in a private practice. Biodesign 4-layer tissue grafts (COOK
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Medical) were placed in the tonsillar fossa after tonsillectomy. Patients were then questioned on postoperative pain, need for narcotic use, and days to return to normal diet.
Results:
The main objective to determine feasibility of placement of a bioabsorbable patch was achieved in all 10 cases. The average placement time per side was 10 minutes, adding 20 minutes/case. Patients were seen at either postopeartive days 2 and 10, and patients were questioned about expected level of pain, need for narcotics, and return to normal diet. All patients on average were noticing significant decreases in pain at days 3 and 4, noted with decreased narcotic intake and return to normal diets. No adverse events were noted with the Biodesign® material.
Conclusion: First, the study demonstrates the feasibility of using Biodesign as a bioabsorbable patch after tonsillectomy. Second, the initial results of this pilot study are very encouraging in providing evidence that a non-energy-based device can provide consistent postoperative pain reduction. Further study is warranted to better measure outcomes. Method: From December 2010 to December 2011, 113 OSA patients underwent drug-induced sleep endoscopy in the supine and lateral positions. Obstruction site was classified as soft palate (SP), tongue base (TB), lateral wall (LW), larynx (LX), and no obstruction (NO). Patients with a nonsupine RDI above 10 were classified as nonpositioners (NP) and below 10 as positioners (PR).
Sleep Medicine Changes of Site of Obstruction in
Results: There were 85 men and 28 women with a mean age of 42.7 years. Mean BMI was 27.1, and mean RDI was 37.5. The PR (position responder) group was 49 patients, which accounts for 43.36% of all enrolled OSA patients (113 patients). Their site of obstruction in supine position was TB (20), SP(13), LW(11), and LX(5). In the lateral position 32 showed no obstruction, 8 showed obstruction at the LW, and the remaining 9 patients showed obstruction at SP. In the NP group (64, 57%), site of obstruction in the supine position was TB (20), SP (11), LW (26), and LX (7). In the lateral position, obstruction was observed at the LW (39), SP (16), TB (5), and LX (4).
Conclusion:
Site of obstruction according to sleep position was evaluated for the first time. TB obstruction showed marked improvement when sleep position changed from supine to lateral. Obstruction in the lateral position was mostly due to obstruction at the LW, and position dependency is mostly determined by LW collapsibility. Method: Pilot prospective study of 16 patients with moderate to severe OSA recruited over 1 year at a tertiary care center. These patients were evaluated in the clinic with the flexible nasendoscope and subsequently underwent full PSG and DISE with midazolam.
Sleep Medicine
Results: The 16 patients studied had a mean AHI of 65 (range, 18.8 to 129). Fifteen out of 16 patients (93.7%) were found to have multi segment obstruction on DISE according to the original grading proposed by Pringle and Croft. Comparing the various awake dynamic maneuvers against DISE as a gold standard, MM was found to have sensitivity of 53%, FTP had a sensitivity of 80%, and EEPBOT had a sensitivity of 93%. Because of the skewed nature of the results (only 1 out of 16 patients [6.3%] was classified as not having obstruction), specificity results had no statistical value.
Conclusion: This small pilot study showed a good correlation between EEPBOT, FTP, and DISE. A poorer correlation between MM and DISE is seen. Our results suggest that EEPBOT and FPP are superior to MM in evaluating tonguebase obstruction in OSA; however, further research is required to support these findings.
Sleep Medicine da Vinci System for treatment of Sleep apnea Syndrome
Peter M. Baptista, MD, PhD (presenter); Juan Alcalde, MD; Jorge de Abajo, MD; Vivian Gallegos, MD Objective: Tongue base hypertrophy is frequently related with sleep apnea-hypopnea syndrome (OSAHS). The objectives were: 1) To determine which patients are candidates for tongue base resection by means of trans ral robotic Surgery (TORS). 2) To evaluate the clinical results of this technique associated or not with other treatments.
